# 498P Efficacy and safety of triptorelin pamoate 22.5 mg 6-month formulation in Chinese patients with locally advanced or metastatic prostate cancer: A multicentre, single-arm phase IIIb study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/498p-efficacy-and-safety-of-triptorelin-pamoate-22-5-mg-6-month-formulation-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | S. Jiang,H. Su,H. Guo,M. Liu,Y. Li,G. Shi,J. Bi,Z. Chen,M. Chen,W. He,Z. Yan,J. Zhang,B. Xue,J-Y Zou,X. Shi,D. Ye |
| Citations | 0 |
| DOI | 10.1016/j.annonc.2025.10.393 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7116944274 |
| Type | article |
| Year | 2025 |

## Paper authors

- [H. Guo](https://scholariq.org/researchers/h-guo/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.